Papanikos; Alexandra
Patent Applications and Registrations
Patent applications and USPTO patent grants for Papanikos; Alexandra.The latest application filed is for "pyrazolyl quinoxaline kinase inhibitors".
- Papanikos; Alexandra - Antwerpen BE
- Papanikos; Alexandra - Antwerp BE
- Papanikos; Alexandra - Berchem BE
- Papanikos, Alexandra - St. Kilda East AU
- Papanikos; Alexandra - Kilda East AU
| Patent | Date |
|---|---|
| Pyrazolyl Quinoxaline Kinase Inhibitors App 20220135544 - SAXTY; Gordon ; et al. | 2022-05-05 |
| Pyrazolyl Quinoxaline Kinase Inhibitors App 20200131153 - SAXTY; Gordon ; et al. | 2020-04-30 |
| Pyrazolyl quinoxaline kinase inhibitors Grant 10,519,137 - Saxty , et al. Dec | 2019-12-31 |
| Macrocyclic quinazole derivatives and their use as MTKI Grant 10,208,062 - Freyne , et al. Feb | 2019-02-19 |
| Pyrazolyl Quinoxaline Kinase Inhibitors App 20180127397 - SAXTY; Gordon ; et al. | 2018-05-10 |
| Pyrazolyl quinoxaline kinase inhibitors Grant 9,850,228 - Saxty , et al. December 26, 2 | 2017-12-26 |
| Macrocyclic Quinazole Derivatives And Their Use As Mtki App 20170320894 - FREYNE; Eddy Jean Edgard ; et al. | 2017-11-09 |
| Macrocyclic quinazole derivatives and their use as MTKI Grant 9,688,691 - Freyne , et al. June 27, 2 | 2017-06-27 |
| Pyrazolyl Quinoxaline Kinase Inhibitors App 20160311800 - SAXTY; Gordon ; et al. | 2016-10-27 |
| Pyrazolyl quinoxaline kinase inhibitors Grant 9,464,071 - Saxty , et al. October 11, 2 | 2016-10-11 |
| Pyrazolyl Quinoxaline Kinase Inhibitors App 20150105368 - SAXTY; Gordon ; et al. | 2015-04-16 |
| Pyrazolyl quinoxaline kinase inhibitors Grant 8,895,601 - Saxty , et al. November 25, 2 | 2014-11-25 |
| Macrocyclic Quinazole Derivatives And Their Use As Mtki App 20140256714 - FREYNE; Eddy Jean Edgard ; et al. | 2014-09-11 |
| Imidazo [1,2-A]pyridine derivatives as FGFR kinase inhibitors for use in therapy Grant 8,722,687 - Saxty , et al. May 13, 2 | 2014-05-13 |
| MTKI quinazoline derivatives Grant 8,492,377 - Papanikos , et al. July 23, 2 | 2013-07-23 |
| Bicyclic heterocyclyl derivatives as FGFR kinase inhibitors for therapeutic use Grant 8,481,531 - Saxty , et al. July 9, 2 | 2013-07-09 |
| Pyrazolyl Quinazoline Kinase Inhibitors App 20130072457 - Saxty; Gordon ; et al. | 2013-03-21 |
| Imidazo [1,2-a]pyridine Derivatives As Fgfr Kinase Inhibitors For Use In Therapy App 20120041000 - Saxty; Gordon ; et al. | 2012-02-16 |
| Bicyclic Heterocyclyl Derivatives As Fgfr Kinase Inhibitors For Therapeutic Use App 20120035171 - Saxty; Gordon ; et al. | 2012-02-09 |
| Macrocyclic Quinazole Derivatives And Their Use As Mtki App 20100152174 - Freyne; Eddy Jean Edgard ; et al. | 2010-06-17 |
| Mtki Quinazoline Derivatives App 20100029627 - Papanikos; Alexandra ; et al. | 2010-02-04 |
| Pharmaceutical agents App 20050159437 - Jarrott, Bevyn ; et al. | 2005-07-21 |
| Pharmaceutical agents Grant 6,881,740 - Jarrott , et al. April 19, 2 | 2005-04-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 